Found 8 matching trials
TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers
PHASE1Doctors leading this study hope to learn about the safety and effectiveness...
Status
Active Not Recruiting
Location
University of Chicago
A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer
PHASE2This is a study of HB-202/HB-201 alternating 2-vector therapy with pembroli...
Location
Multiple Locations
A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers
PHASE1This is a First in Human (FIH) Phase I/II, multinational, multicenter, open...
Location
O'Neal Comprehensive Cancer Center at UAB
A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)
EARLY_PHASE1The researchers are doing this study to find out if HB-202/HB-201 is a feas...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Validation of a Diagnostic Test for Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Anti-coagulated Blood
NAThe primary objective of the study is to assess the accuracy of the SD Bios...
A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer
EARLY_PHASE1This Window of Opportunity clinical trial will examine the immunologic effe...
Location
Froedtert Hospital and the Medical College of Wisconsin
Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US
NAThe primary objective of this study is to assess the accuracy of the SD Bio...
Location
Fred Hutchison Prevention Center
Evaluation of a Diagnostic to Identify Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Brazil
NATh objectives of this study are:
* To determine the performance of G6PD te...
Location
Tropical Medicine Foundation Doctor Heitor Vieira Dourado